Novo Nordisk Archives - Page 4 of 5

Obesity Update: CGX-926 Oral Debut, 18% Weight Loss from KAI-9531, Vivani’s…

Fractyl’s Gene Therapy Breakthrough, Verdiva’s Oral GLP-1 Pipeline, Viking’s…

Eccogene’s Oral GLP-1 Debut, Novo’s 24% Weight Loss Win, Lilly’s Q3 Reveal…

Obesity 🚨 Breakthroughs in Obesity Drug Development You Need to Know! In this…

Obesity Advancements: Arrowhead’s RNAi Debut, Lilly’s $870M Bet, Novo’s Triple…

Obesity Advancements: Regeneron’s Triplet Breakthrough, $2B Hansoh Deal,…

Obesity Advancements: Ascletis’ Combo Trial, Mazdutide’s NEJM Breakthrough,…

🧬 Latest Breakthroughs in Endocrinology: Gene Therapy, Semaglutide, AI &…

Obesity Latest News: GLP-1 Pill Update, Discount Wars & Pharma Shakeups In…

GLP-1 Pills, Court Rulings & Obesity Market Shakeups In this week's…

💊 Obesity Watch: GLP-1 Pills, Trial Updates & Global Market Moves …

💊 Obesity Watch: AI, GLP-1 Rivals, and $Billion Pharma Moves In this week's…